According to the "2021 White Paper on Exercise and Sleep" released by the Chinese Sleep Research Association and other institutions, more than 300 million people in China currently have sleep disorders. One of the most serious sleep disorders is obstructive sleep apnea (OSA), a condition in which people periodically experience partial or complete upper airway obstruction during sleep, characterized by apnea and hypopnea.
The number of people suffering from OSA in China has reached 176 million, ranking first in the world, and more than 66 million of them need active treatment. However, the detection rate of OSA in China is very low, only around 1%. In addition, among the people with OSA, the trend of younger people is becoming more and more serious, and there are even many cases of preschool children suffering from OSA. Due to the high prevalence of OSA, which seriously affects the quality of life and is very likely to cause related cardiovascular complications with high mortality rate, which aggravates the disease burden of patients, with the continuous increase in the number of patients and the improvement of patients' awareness of health management and disease prevention, the demand for OSA diagnosis and treatment in China will be further released.
Source: Bergers Consulting
At present, the market size of sleep monitors has increased from 28.1 million yuan to about 66.1 million yuan, with a compound annual growth rate of 23.8%. According to statistics, the development potential of sleep monitors is significant, especially by the pre-70s middle-aged and elderly consumers, while the younger generation prefers to use smart wearable products to monitor and assist sleep.
In addition, sleep apnea machines are gradually becoming an option for insomnia patients. The market size of China's sleep apnea machine was 694 million yuan, a year-on-year increase of 18.2%. In 2020, the market size of China's sleep apnea machine was 1.204 billion yuan, a year-on-year increase of 16.4%.
Source: Bergers Consulting
In China's sleep apnea market, Philips and ResMed are the manufacturers with the highest proportion of China's sleep apnea market, accounting for 34.6% and 32.5% respectively, Jardine Jiaye ranks third with a market share of 6.1%, and Yuyue Medical ranks fourth with a market share of 4.6%. The rest of the Chinese enterprises account for a relatively small proportion and are relatively scattered.
Source: Bergers Consulting